BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

759 related articles for article (PubMed ID: 23117489)

  • 1. Phosphorylated neurofilament heavy subunit (pNF-H) in peripheral blood and CSF as a potential prognostic biomarker in amyotrophic lateral sclerosis.
    Boylan KB; Glass JD; Crook JE; Yang C; Thomas CS; Desaro P; Johnston A; Overstreet K; Kelly C; Polak M; Shaw G
    J Neurol Neurosurg Psychiatry; 2013 Apr; 84(4):467-72. PubMed ID: 23117489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoreactivity of the phosphorylated axonal neurofilament H subunit (pNF-H) in blood of ALS model rodents and ALS patients: evaluation of blood pNF-H as a potential ALS biomarker.
    Boylan K; Yang C; Crook J; Overstreet K; Heckman M; Wang Y; Borchelt D; Shaw G
    J Neurochem; 2009 Dec; 111(5):1182-91. PubMed ID: 19765193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphorylated neurofilament heavy chain levels in paired plasma and CSF of amyotrophic lateral sclerosis.
    Li S; Ren Y; Zhu W; Yang F; Zhang X; Huang X
    J Neurol Sci; 2016 Aug; 367():269-74. PubMed ID: 27423602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CSF neurofilament proteins as diagnostic and prognostic biomarkers for amyotrophic lateral sclerosis.
    Rossi D; Volanti P; Brambilla L; Colletti T; Spataro R; La Bella V
    J Neurol; 2018 Mar; 265(3):510-521. PubMed ID: 29322259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurofilament Subunit L Levels in the Cerebrospinal Fluid and Serum of Patients with Amyotrophic Lateral Sclerosis.
    Gong ZY; Lv GP; Gao LN; Lu Y; Guo J; Zang DW
    Neurodegener Dis; 2018; 18(2-3):165-172. PubMed ID: 29898446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurofilament levels as biomarkers in asymptomatic and symptomatic familial amyotrophic lateral sclerosis.
    Weydt P; Oeckl P; Huss A; Müller K; Volk AE; Kuhle J; Knehr A; Andersen PM; Prudlo J; Steinacker P; Weishaupt JH; Ludolph AC; Otto M
    Ann Neurol; 2016 Jan; 79(1):152-8. PubMed ID: 26528863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrospinal fluid levels of chromogranin A and phosphorylated neurofilament heavy chain are elevated in amyotrophic lateral sclerosis.
    Kaiserova M; Grambalova Z; Otruba P; Stejskal D; Prikrylova Vranova H; Mares J; Mensikova K; Kanovsky P
    Acta Neurol Scand; 2017 Oct; 136(4):360-364. PubMed ID: 28185258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurofilament light chain: A prognostic biomarker in amyotrophic lateral sclerosis.
    Lu CH; Macdonald-Wallis C; Gray E; Pearce N; Petzold A; Norgren N; Giovannoni G; Fratta P; Sidle K; Fish M; Orrell R; Howard R; Talbot K; Greensmith L; Kuhle J; Turner MR; Malaspina A
    Neurology; 2015 Jun; 84(22):2247-57. PubMed ID: 25934855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurofilaments in Sporadic and Familial Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-Analysis.
    Shahim P; Norato G; Sinaii N; Zetterberg H; Blennow K; Chan L; Grunseich C
    Genes (Basel); 2024 Apr; 15(4):. PubMed ID: 38674431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic and prognostic significance of neurofilament light chain NF-L, but not progranulin and S100B, in the course of amyotrophic lateral sclerosis: Data from the German MND-net.
    Steinacker P; Huss A; Mayer B; Grehl T; Grosskreutz J; Borck G; Kuhle J; Lulé D; Meyer T; Oeckl P; Petri S; Weishaupt J; Ludolph AC; Otto M
    Amyotroph Lateral Scler Frontotemporal Degener; 2017 Feb; 18(1-2):112-119. PubMed ID: 27819158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurofilaments as Biomarkers for Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-Analysis.
    Xu Z; Henderson RD; David M; McCombe PA
    PLoS One; 2016; 11(10):e0164625. PubMed ID: 27732645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrospinal Fluid Levels of Phosphorylated Neurofilament Heavy as a Diagnostic Marker of Canine Degenerative Myelopathy.
    Toedebusch CM; Bachrach MD; Garcia VB; Johnson GC; Katz ML; Shaw G; Coates JR; Garcia ML
    J Vet Intern Med; 2017 Mar; 31(2):513-520. PubMed ID: 28186658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multicenter evaluation of neurofilaments in early symptom onset amyotrophic lateral sclerosis.
    Feneberg E; Oeckl P; Steinacker P; Verde F; Barro C; Van Damme P; Gray E; Grosskreutz J; Jardel C; Kuhle J; Koerner S; Lamari F; Amador MDM; Mayer B; Morelli C; Muckova P; Petri S; Poesen K; Raaphorst J; Salachas F; Silani V; Stubendorff B; Turner MR; Verbeek MM; Weishaupt JH; Weydt P; Ludolph AC; Otto M
    Neurology; 2018 Jan; 90(1):e22-e30. PubMed ID: 29212830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated Levels of IFN-γ in CSF and Serum of Patients with Amyotrophic Lateral Sclerosis.
    Liu J; Gao L; Zang D
    PLoS One; 2015; 10(9):e0136937. PubMed ID: 26332465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrospinal Fluid Neurofilaments May Discriminate Upper Motor Neuron Syndromes: A Pilot Study.
    Zucchi E; Bedin R; Fasano A; Fini N; Gessani A; Vinceti M; Mandrioli J
    Neurodegener Dis; 2018; 18(5-6):255-261. PubMed ID: 30428468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune reactivity to neurofilament proteins in the clinical staging of amyotrophic lateral sclerosis.
    Puentes F; Topping J; Kuhle J; van der Star BJ; Douiri A; Giovannoni G; Baker D; Amor S; Malaspina A
    J Neurol Neurosurg Psychiatry; 2014 Mar; 85(3):274-8. PubMed ID: 24078718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of CSF NfL and tau in ALS.
    Schreiber S; Spotorno N; Schreiber F; Acosta-Cabronero J; Kaufmann J; Machts J; Debska-Vielhaber G; Garz C; Bittner D; Hensiek N; Dengler R; Petri S; Nestor PJ; Vielhaber S
    J Neurol; 2018 Nov; 265(11):2633-2645. PubMed ID: 30187162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated levels of ferritin in the cerebrospinal fluid of amyotrophic lateral sclerosis patients.
    Zheng Y; Gao L; Wang D; Zang D
    Acta Neurol Scand; 2017 Aug; 136(2):145-150. PubMed ID: 27804118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomarker-based predictive models for prognosis in amyotrophic lateral sclerosis.
    Su XW; Simmons Z; Mitchell RM; Kong L; Stephens HE; Connor JR
    JAMA Neurol; 2013 Dec; 70(12):1505-11. PubMed ID: 24145899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic and prognostic power of CSF Tau in amyotrophic lateral sclerosis.
    Scarafino A; D'Errico E; Introna A; Fraddosio A; Distaso E; Tempesta I; Morea A; Mastronardi A; Leante R; Ruggieri M; Mastrapasqua M; Simone IL
    J Neurol; 2018 Oct; 265(10):2353-2362. PubMed ID: 30116940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.